Sohlberg S, Martinsen B, Horsberg T E, Søli N E
Department of Pharmacology, Microbiology and Food Hygiene, Norwegian College of Veterinary Medicine, Oslo, Norway.
J Vet Pharmacol Ther. 1996 Dec;19(6):460-5. doi: 10.1111/j.1365-2885.1996.tb00083.x.
The antimicrobial drug flumequine was given intravascularly and orally to cannulated and non-cannulated Atlantic salmon (Salmo salar) in sea water at 11 degrees C. The cannulated fish were divided into two groups, which were given flumequine (25 mg/kg) intravenously into the caudal vein (n = 8) and orally via a stomach tube down the oesophagus (n = 8). After a washout period of 2 days, the intravenously administered fish were given the drug orally, and the orally administered fish were given the drug intravenously. Blood samples were taken at different time points after drug administration through a cannula inserted into the dorsal aorta. The fish in the non-cannulated group were either given flumequine intravenously or orally, and blood samples were collected by killing five fish at predetermined time points after administration. The haematocrit values were measured in all the fish daily for 4 days after drug administration and thereafter, in all the collected blood samples throughout the whole experiment. The haematocrit values differed significantly between the cannulated and the non-cannulated fish. We found low haematocrit values and slow drug elimination in the cannulated groups, compared with higher haematocrit values and faster drug elimination in the non-cannulated groups, but further investigations are needed to prove any causal relations of this observation. The volume of distribution (Vd(ss)) was twice as large in the cannulated groups compared with the non-cannulated group, in the fish administered the drug intravenously. In the last part of the elimination phase, the half-lives differed considerably between the cannulated and the non-cannulated groups both after oral and intravenous administration. The slower depletion of the drug concentration in the plasma of the cannulated fish is due to the large Vd(ss) as there are only small differences in clearance (ClT) between the groups. In this study the elimination of flumequine in cannulated Atlantic salmon differed from the elimination of flumequine in non-cannulated Atlantic salmon.
在11摄氏度的海水中,将抗菌药物氟甲喹经血管内和口服给予有插管和无插管的大西洋鲑(Salmo salar)。有插管的鱼被分为两组,分别经尾静脉静脉注射氟甲喹(25毫克/千克)(n = 8)和通过胃管经食管口服给药(n = 8)。经过2天的洗脱期后,静脉给药的鱼改为口服给药,口服给药的鱼改为静脉给药。给药后通过插入背主动脉的插管在不同时间点采集血样。无插管组的鱼要么静脉注射要么口服氟甲喹,并在给药后的预定时间点处死五条鱼来采集血样。给药后4天内每天测量所有鱼的血细胞比容值,此后在整个实验过程中对所有采集的血样都进行测量。有插管和无插管的鱼的血细胞比容值有显著差异。我们发现,与无插管组较高的血细胞比容值和较快的药物消除相比,有插管组的血细胞比容值较低且药物消除较慢,但需要进一步研究来证明这一观察结果的任何因果关系。在静脉给药的鱼中,有插管组的分布容积(Vd(ss))是无插管组的两倍。在消除期的最后阶段,口服和静脉给药后,有插管和无插管组的半衰期差异都很大。有插管的鱼血浆中药物浓度下降较慢是由于Vd(ss)较大,因为两组之间的清除率(ClT)只有很小的差异。在本研究中,有插管的大西洋鲑体内氟甲喹的消除与无插管的大西洋鲑体内氟甲喹的消除不同。